Status:
UNKNOWN
CCTA-guided Ultraselective Invasive Coronary Angiography
Lead Sponsor:
Catharina Ziekenhuis Eindhoven
Collaborating Sponsors:
The Elisabeth-TweeSteden Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Coronary artery disease (CAD) is the leading cause of death in adults in the United States.\[1\] In the latest guidelines of the European Society of Cardiology anatomical non-invasive imaging by coron...
Detailed Description
Study design \& patient population The study is a dual-center prospective registry in two hospitals in the Netherlands. All patients eligible for participation in this registry are aged 18-80 years o...
Eligibility Criteria
Inclusion
- Patients undergoing invasive coronary angiography because of abnormalities found on CCTA in either the left or right coronary artery and no or minimal stenosis (CAD-RADS 0-1; 0-24% stenosis) in the contralateral coronary artery within 90 days.
Exclusion
- Refusal of informed consent
- Abnormalities in both coronary arteries on CCTA
- Prior PCI
- Prior coronary artery bypass grafting (CABG)
- Major allergy to iodinated contrast agent
- Inability to provide informed consent, and/or known pregnancy.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04907786
Start Date
July 1 2021
End Date
December 31 2022
Last Update
August 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catharina Hospital
Eindhoven, North Brabant, Netherlands, 5623 EJ